Banner - NPPA Connect

NP/PA Connect
News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

Opinion|Videos|February 10, 2025

Laser Therapy Protocols in Patients With Melasma and Darker Skin Tones

Author(s)Corey L. Hartman, MD, FAAD

A panelist discusses how using conservative laser settings, proper skin cooling, and careful patient selection is crucial when treating melasma and darker skin types to minimize post-inflammatory hyperpigmentation risks.

Episodes in this series

1 KOL is featured in this series.

EP. 1 Choosing Effective Laser Devices for Improving Skin Tone and Texture

1 KOL is featured in this series.

EP. 2 Comparing Fractional and Non-Fractional Lasers for Skin Rejuvenation

1 KOL is featured in this series.

EP. 3 Deciding When to Use Combination Therapies With Lasers

1 KOL is featured in this series.

EP. 4 Advancements in Laser Safety and Precision for Diverse Skin Types

1 KOL is featured in this series.

EP. 5 Challenges of Rapid Advancements in Laser Technology

1 KOL is featured in this series.

EP. 6 Expanding Laser Benefits for Diverse Patient Populations

EP. 7 Advancing Care With Laser and Light-Based Technology in Dermatology

EP. 7 Advancing Care With Laser and Light-Based Technology in Dermatology

EP. 8 Adjusting Laser Therapy Treatment Based on Patient Access, History, and Motivation

EP. 8 Adjusting Laser Therapy Treatment Based on Patient Access, History, and Motivation

EP. 9 Benefits of a Combination Treatment Approach Using Laser Therapy

EP. 9 Benefits of a Combination Treatment Approach Using Laser Therapy

1 expert is featured in this series.

EP. 10 Using Laser Therapy for Varied Skin Types and Stages of Acne

1 expert is featured in this series.

EP. 11 Laser Therapy as an Alternative or Combination Treatment for Acne

1 expert is featured in this series.

EP. 12 Efficacy and Safety of Laser Treatment for Patients With Acne

1 expert is featured in this series.

EP. 13 Integrated Approaches to Treating Rosacea With Lasers

1 expert is featured in this series.

EP. 14 Managing Expectations and Minimizing Laser Complications

1 expert is featured in this series.

EP. 15 Melanocyte Preservation and Future Directions for Laser Technology

1 expert is featured in this series.

EP. 16 Patient Goals and Outcomes for Treating Pigmentary Issues With Laser Therapy

1 expert is featured in this series.

EP. 17 Laser Therapy Protocols in Patients With Melasma and Darker Skin Tones

1 expert is featured in this series.

EP. 18 Tolerability and Postcare Benefits of Laser Therapy for Patients With Pigmentary Disorders

EP. 19 Tailored Laser and Light-Based Therapies for Acne, Skin of Color, and Inflammatory Conditions

EP. 19 Tailored Laser and Light-Based Therapies for Acne, Skin of Color, and Inflammatory Conditions

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

1 expert is featured in this series

Case 1: Choosing Non-Steroidal Topicals for Intertriginous Psoriasis

ByTina Bhutani-Jacques, MD

July 20th 2026

1 expert is featured in this series

The Ongoing Role of Topical Therapy in Plaque Psoriasis Management

ByTina Bhutani-Jacques, MD

July 20th 2026

2 experts are featured in this series

The Safety of Advanced Topical Therapies in Inflammatory Dermatoses

ByPeter Lio, MD,Alexandra K. Golant, MD

July 15th 2026

2 experts are featured in this series

Understanding Corticosteroid-Related Medical-Legal Risks in Inflammatory Dermatoses

ByPeter Lio, MD,Alexandra K. Golant, MD

July 15th 2026

Setting Expectations: Treatment Timelines, Adherence, and Monitoring in Vitiligo

ByNada Elbuluk, MD, MSc, FAAD,Susan Taylor, MD, FAAD

July 14th 2026

Latest CME

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

New Review Confirms How Nonmedicated Skin Care Vehicles Drive Clinical Improvement

Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites

Dermatology Times Spot Test: July 19, 2026

Soficitinib (ICP-332) Meets Primary Endpoint in Phase 3 Trial for Moderate to Severe AD

ED Treatment Gaps Persist for Pediatric Atopic Dermatitis